Rapid and Specific Identification of Emerging Trichophyton mentagrophytes Genotype VII Using an In-House Developed and Validated Real-Time PCR Assay

This study presents a rapid, highly sensitive, and specific in-house TaqMan-based real-time PCR assay that successfully differentiates the emerging sexually transmitted *Trichophyton mentagrophytes* genotype VII from other related fungal pathogens, offering a significantly faster alternative to traditional sequencing methods for improved patient care and infection control.

The Gist

Imagine a vast family of fungi called the Trichophyton clan. Within this huge family, there are 28 different "cousins" (genotypes) that look almost identical to the naked eye. One specific cousin, known as Genotype VII, has recently shown up causing a very nasty, painful, and stubborn skin infection that spreads through intimate contact. Because this new cousin looks so much like its relatives, doctors have struggled to tell them apart quickly.

This paper describes the creation of a new molecular "ID scanner" designed specifically to catch this one tricky cousin.

Here is how the scientists built this scanner, explained in everyday terms:

1. The "Wanted Poster" (The Target)
Instead of trying to recognize the whole fungus, the scientists looked for three tiny, unique "typos" (single-nucleotide polymorphisms) in the fungus's genetic code. Think of these typos as a specific fingerprint or a unique scratch on a car that only Genotype VII has. They focused on a specific section of the fungus's DNA called the "ITS1 region" to find these marks.

2. The "Lock and Key" Upgrade (The Primer Design)
To make sure their scanner didn't accidentally ring the alarm for the wrong fungus, they added a special safety feature. They intentionally made their "keys" (the primers used in the test) fit just slightly wrong for any fungus that wasn't Genotype VII. It's like designing a key that fits perfectly into the Genotype VII lock but is guaranteed to jam if you try to use it on any other lock in the family. This ensures the test only screams "Found it!" when it sees the real target.

3. The "Super-Sensitive Sniffer" (Sensitivity)
The new test is incredibly sharp. It can detect the fungus even if there is only a microscopic speck of it present—specifically, as little as 0.0002 nanograms of DNA. That is like finding a single grain of sand in a swimming pool.

4. The "No False Alarms" Record (Specificity)
When they tested this scanner against a huge lineup of 497 different mold samples (including close relatives and distant cousins), it only flagged the 47 samples that were actually Genotype VII. It didn't get confused by anyone else. When the test said "negative," it was 100% correct.

5. The "Speed Run" (Turnaround Time)
The biggest win is the speed.

• The Old Way: Using traditional methods (Sanger sequencing) is like sending a letter across the ocean and waiting for a reply; it takes 7 to 10 days.
• The New Way: This new test is like sending a text message. Once the DNA is ready, the whole process takes just one day.

The Bottom Line
The scientists successfully built and tested a fast, accurate, and highly sensitive tool that acts like a specialized metal detector for this specific emerging fungus. By using this new "TaqMan" scanner, they can identify the infection much faster than before, helping to confirm the diagnosis without the long wait of traditional methods.

Technical Summary

Technical Summary: Rapid and Specific Identification of Emerging Trichophyton mentagrophytes Genotype VII

Problem Statement
Trichophyton mentagrophytes genotype VII (TmVII) has emerged as a significant cause of sexually transmitted dermatophytosis, presenting clinically with inflammatory, erythematous-squamous, painful, and persistent lesions. TmVII belongs to the T. interdigitale/T. mentagrophytes Species Complex (TiTmSC), a group comprising 28 distinct genotypes. The clinical and epidemiological challenge lies in the difficulty of rapidly and specifically differentiating TmVII from other closely related genotypes within this complex using traditional methods, which are often time-consuming and lack the necessary specificity for immediate clinical decision-making.

Methodology
To address the need for rapid differentiation, the authors developed and validated an in-house real-time polymerase chain reaction (rt-PCR) assay. The methodology involved the following key technical components:

• Target Selection: The assay targets three unique single-nucleotide polymorphisms (SNPs) located within the Internal Transcribed Spacer 1 (ITS1) region specific to TmVII.
• Primer Design: To enhance specificity and minimize non-specific amplification, an additional mismatch was intentionally introduced at the 3' ends of both the forward and reverse primers.
• Chemistry: The assay utilizes TaqMan chemistry.
• Validation Parameters: The assay was evaluated for sensitivity (limit of detection), specificity (cross-reactivity with other fungal pathogens), and reproducibility. A cycle threshold (Ct) cutoff of 37 was established for positive identification.
• Comparative Analysis: The performance of the rt-PCR assay was compared against conventional ITS-PCR followed by Sanger sequencing using a cohort of 497 mold isolates.

Key Results

• Sensitivity: The assay demonstrated high sensitivity, with a detection limit of 0.0002 ng of TmVII genomic DNA.
• Specificity: No cross-reactivity was observed with either closely or distantly related fungal pathogens when the Ct cutoff of 37 was applied.
• Concordance: Among 497 tested mold isolates, 47 were confirmed as TmVII by the rt-PCR assay. These results showed 100% concordance with the conventional ITS-PCR/Sanger sequencing method.
• Turnaround Time: The rt-PCR assay offers a significantly reduced turnaround time of one day following DNA extraction, compared to the seven to ten days typically required for Sanger sequencing.

Significance and Claims
The paper asserts that this work represents the first rapid molecular assay developed using TaqMan chemistry specifically for the identification of TmVII. The authors claim that the assay's combination of high sensitivity, specificity, reproducibility, and speed will enhance patient care and support infection control measures by enabling the rapid detection of this emerging pathogen. The study concludes that the assay provides a robust alternative to slower conventional sequencing methods for differentiating TmVII within the TiTmSC.